Duncan Williams Upgrades Inspire Pharma (ISPH) to Hold; Starting Fresh
Tweet Send to a Friend
Duncan Williams upgraded Inspire Pharma (NASDAQ: ISPH) from Sell to Hold.
Duncan analyst says, "We update our investment thesis: (1) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Duncan analyst says, "We update our investment thesis: (1) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
